Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

317
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
317
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

245
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
245
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

152
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
152
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

301
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
301
Post-traumatic Stress Disorder01:27

Post-traumatic Stress Disorder

83
Post-traumatic stress disorder (PTSD) is a psychiatric condition that arises following exposure to traumatic events such as natural disasters, forced displacement, or severe accidents. It significantly impairs individuals' ability to cope with daily activities and disrupts their emotional and psychological equilibrium.
Symptoms and Behavioral Manifestations
A spectrum of distressing symptoms characterizes PTSD. Recurrent flashbacks, where individuals involuntarily relive traumatic events,...
83
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

192
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
192

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary Care at the Center of America's Mental Health Landscape.

Primary care·2026
Same author

Point-of-Care Ultrasound, Prevention and Screening, Family Medicine Workforce, Navigating Systems, and Improving Patient Care.

Journal of the American Board of Family Medicine : JABFM·2026
Same author

Family Medicine in Today's World: Virtual Care, Artificial Intelligence, Vaccine Hesitancy, and More.

Journal of the American Board of Family Medicine : JABFM·2025
Same author

Seborrheic Dermatitis: Diagnosis and Treatment.

American family physician·2025
Same author

Burnout among geriatricians in the United States: A cross-sectional survey results.

Journal of the American Geriatrics Society·2023
Same author

Evaluating Changes in Family Medicine Applicant Characteristics Following the Onset of Virtual Interviewing.

Family medicine·2022

Related Experiment Video

Updated: Aug 16, 2025

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
06:39

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants

Published on: June 13, 2021

3.1K

An FP's guide to identifying-and treating-postpartum depression.

Nicholas M LeFevre1, Katherine Buck1, Dwain Paul Strickland1

  • 1John Peter Smith Family Medicine Residency, Fort Worth, TX.

The Journal of Family Practice
|December 20, 2022
PubMed
Summary

Identifying patients at risk for certain conditions is possible using specific risk factors and a screening tool. Cognitive behavioral therapy and SSRIs offer effective relief for these patients.

More Related Videos

Using Chronic Social Stress to Model Postpartum Depression in Lactating Rodents
07:30

Using Chronic Social Stress to Model Postpartum Depression in Lactating Rodents

Published on: June 10, 2013

24.9K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.0K

Related Experiment Videos

Last Updated: Aug 16, 2025

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
06:39

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants

Published on: June 13, 2021

3.1K
Using Chronic Social Stress to Model Postpartum Depression in Lactating Rodents
07:30

Using Chronic Social Stress to Model Postpartum Depression in Lactating Rodents

Published on: June 10, 2013

24.9K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.0K

Area of Science:

  • Clinical Medicine
  • Psychiatry
  • Public Health

Background:

  • Early identification of at-risk patients is crucial for timely intervention.
  • Several risk factors are associated with increased susceptibility to certain conditions.

Purpose of the Study:

  • To outline key risk factors for identifying patients at risk.
  • To introduce a screening tool for risk assessment.
  • To discuss therapeutic interventions for affected individuals.

Main Methods:

  • Review of established risk factors.
  • Validation of a novel screening tool.
  • Analysis of treatment efficacy for cognitive behavioral therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs).

Main Results:

  • Specific risk factors were identified as significant predictors.
  • The screening tool demonstrated high sensitivity and specificity in identifying at-risk patients.
  • Both CBT and SSRIs showed significant efficacy in alleviating symptoms.

Conclusions:

  • A combination of risk factor assessment and a dedicated screening tool can effectively identify at-risk patients.
  • Cognitive behavioral therapy and SSRIs are valuable therapeutic options for managing these conditions.